| TARGANTA THERAPEUTICS CORP. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120035097 | METHODS OF TREATING BACTERIAL INFECTIONS USING ORITAVANCIN - The present invention is directed to methods of treating a bacterial infection in a subject through the administration of a therapeutically effective amount of a glycopeptide antibiotic to a subject having a bacterial infection. The effective amount of the glycopeptide antibiotic that is administered to the subject provides a fraction of the glycopeptide antibiotic administered to the subject bound to serum proteins within the subject and within a selected range. | 02-09-2012 |
| 20110201546 | METHODS OF TREATMENT USING SINGLE DOSES OF ORITAVANCIN - Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against a wide range of bacteria. Methods for the treatment, prophylaxis and prevention of bacterial infection and disease in animals, including humans, using a single dose of oritavancin over the course of therapy, are described. | 08-18-2011 |
| 20110178001 | PHOSPHONATED RIFAMYCINS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS - The present invention relates to phosphonated Rifamycins, and methods of making and using such compounds. These compounds are useful as antibiotics for prophylaxis and/or the treatment of bone and joint infections, especially for the prophylaxis and/or treatment of osteomyelitis. | 07-21-2011 |
| 20110046041 | METHODS OF INHIBITING AND TREATING BIOFILMS USING GLYCOPEPTIDE ANTIBIOTICS - The present invention is directed to methods of inhibition, delay of formation, treatment, prophylaxis and/or prevention of infections caused by bacteria that exhibit tolerance to antimicrobial agents, including slow growing, stationary-phase and biofilm forming bacteria, through the use of glycopeptide antibiotics, such as oritavancin. | 02-24-2011 |
| 20100311646 | METHOD OF INHIBITING CLOSTRIDIUM DIFFICILE BY ADMINISTRATION OF ORITAVANCIN - Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against both a vegetative form of | 12-09-2010 |
| 20100041585 | USE OF ORITAVANCIN FOR PREVENTION AND TREATMENT OF ANTHRAX - Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against | 02-18-2010 |
